AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,635 | -31.7% | 10,873 | -26.3% | 0.00% | 0.0% |
| Q2 2023 | $24,357 | +221327.3% | 14,762 | +59.0% | 0.00% | – |
| Q1 2023 | $11 | +120.0% | 9,282 | +85.8% | 0.00% | – |
| Q4 2022 | $5 | -100.0% | 4,995 | -85.7% | 0.00% | -100.0% |
| Q3 2022 | $41,000 | +70.8% | 34,875 | -8.6% | 0.00% | 0.0% |
| Q2 2022 | $24,000 | -63.1% | 38,139 | +52.4% | 0.00% | 0.0% |
| Q1 2022 | $65,000 | +828.6% | 25,027 | +1299.7% | 0.00% | – |
| Q4 2021 | $7,000 | -88.7% | 1,788 | -85.2% | 0.00% | -100.0% |
| Q1 2021 | $62,000 | +158.3% | 12,044 | +167.8% | 0.00% | 0.0% |
| Q4 2020 | $24,000 | -73.9% | 4,497 | -76.2% | 0.00% | 0.0% |
| Q3 2020 | $92,000 | +1740.0% | 18,921 | +1824.8% | 0.00% | – |
| Q2 2020 | $5,000 | -89.4% | 983 | -95.5% | 0.00% | -100.0% |
| Q1 2020 | $47,000 | -39.7% | 21,622 | +60.8% | 0.00% | -50.0% |
| Q4 2019 | $78,000 | -17.0% | 13,450 | -54.5% | 0.01% | 0.0% |
| Q3 2019 | $94,000 | +1242.9% | 29,536 | +3005.8% | 0.01% | – |
| Q1 2019 | $7,000 | 0.0% | 951 | -19.3% | 0.00% | -100.0% |
| Q4 2018 | $7,000 | – | 1,179 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 11,503,294 | $36,580,000 | 71.47% |
| WEDBUSH SECURITIES INC | 98,489 | $313,000 | 0.03% |
| Tower Research Capital LLC (TRC) | 29,536 | $94,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 72,296 | $230,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 114,211 | $363,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 60,000 | $191,000 | 0.00% |
| Baker Brothers Advisors | 99,600 | $317,000 | 0.00% |
| MEEDER ASSET MANAGEMENT INC | 8,129 | $26,000 | 0.00% |
| Squarepoint Ops LLC | 40,777 | $130,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 100,089 | $318,000 | 0.00% |